Simplex Trading
PDSB icon

Simplex Trading’s PDS Biotechnology PDSB Stock Holding History

Simplex Trading’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-271
Closed -$288 – 10068
2026
Q1 		$163 Sell
271
-18,835
-99% -$14.2K ﹤0.01% 8848
2025
Q4 		$14.7K Buy
19,106
+6,701
+54% +$6.04K ﹤0.01% 6731
2025
Q3 		$12K Buy
+12,405
New +$14.6K ﹤0.01% 7766
2025
Q2 		– Sell
-7,898
Closed -$10.7K – 9476
2025
Q1 		$9K Sell
7,898
-369
-4% -$525 ﹤0.01% 7188
2024
Q4 		$13K Buy
8,267
+1,570
+23% +$4.16K ﹤0.01% 7017
2024
Q3 		$25K Sell
6,697
-27,144
-80% -$90.6K ﹤0.01% 6505
2024
Q2 		$99K Buy
33,841
+12,188
+56% +$39K ﹤0.01% 5391
2024
Q1 		$85K Sell
21,653
-3,430
-14% -$17.7K ﹤0.01% 5755
2023
Q4 		$124K Sell
25,083
-16,456
-40% -$81.8K ﹤0.01% 5156
2023
Q3 		$209K Sell
41,539
-1,734
-4% -$9.5K ﹤0.01% 4304
2023
Q2 		$217K Buy
43,273
+30,994
+252% +$203K ﹤0.01% 4210
2023
Q1 		$75K Buy
12,279
+555
+5% +$4.54K ﹤0.01% 5480
2022
Q4 		$154K Buy
+11,724
New +$82.7K ﹤0.01% 4550
2022
Q3 		– Sell
-13,426
Closed -$57K – 10642
2022
Q2 		$49K Buy
+13,426
New +$63.8K ﹤0.01% 6518
2022
Q1 		– Sell
-14,410
Closed -$89.5K – 11146
2021
Q4 		$116K Buy
14,410
+8,136
+130% +$87.5K ﹤0.01% 6012
2021
Q3 		$77K Buy
6,274
+100
+2% +$1.25K ﹤0.01% 6979
2021
Q2 		$77K Buy
+6,174
New +$48.2K ﹤0.01% 7101
2018
Q3 		– Sell
-14
Closed – – 7886
2018
Q2 		$0 Sell
14
-43
-75% -$897 ﹤0.01% 7756
2018
Q1 		$1K Buy
+57
New +$15.3K ﹤0.01% 5731

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Simplex Trading's PDSB Position: Q2 2026 in Review

Simplex Trading sold out of PDS Biotechnology (PDSB) in Q2 2026, closing a stake of 271 shares — an estimated $288 sold.

Simplex Trading first reported a position in PDSB in Q1 2018 and held it in 19 quarters. The position peaked at $217K in Q2 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Simplex Trading reported no remaining PDS Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 271 PDS Biotechnology shares in Q2 2026, an estimated $288.
  • Simplex Trading first reported a position in PDS Biotechnology in Q1 2018 and held it in 19 quarters.
  • Simplex Trading's PDS Biotechnology position peaked at $217K in Q2 2023.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.